Lutetium-177 PSMA Therapy for Prostate Cancer - 1 cycle | Döbling Private Clinic, Vienna, Austria

9.70

Vienna, Austria

Overview

Age group

Adults

Type of care

Outpatient

Method

Non-surgical

About the offer

LU 177 PSMA treatment aims to kill cancer cells by beta radiation of the isotope Lutetium-177. The radioactive particle binds explicitly to prostate cancer cells regardless of their location. As a result, the drug destroys the primary tumor and distant metastases. Doctors take blood tests and examine liver and kidney functions before the procedure. But, first, a Ga68-PSMA scan is performed to detect all metastases and determine how well the particular malignant cells accumulate PSMA drug. The patient is injected intravenously for 20 minutes with the Lutetium medication. After that, he stays in a closed ward protected from radiation for two days because he is a beta radiation source. During the action of the radionuclide, he receives drugs to protect the thyroid gland and kidneys, and copious drinking, if necessary, means to reduce nausea and vomiting. The patient can take personal belongings to the ward. They will not become radioactive. The zone of radiation does not exceed 1 millimeter. A day after the therapy, the patient is given a control examination, dosimetry, and kidney scintigraphy. Doctors achieve reduced prostate cancer metastases up to complete remission as Lu 177 treatment results. However, repeating a couple of sessions at 1-2 months intervals might be required.

What’s included

Medical service

Examination

clinical history-taking
medical records review
physical examination
consultation with a nuclear medicine specialist

Laboratory tests

complete blood count (CBC)
biochemical analysis of blood (kidney and liver function tests, electrolytes)
inflammation blood tests
urinalysis
PSA test

Diagnosis

renal scintigraphy with 99mTc-MAG3

Treatment

pre-procedure patient preparation
Lutetium-177 PSMA-DKFZ 617 radioligand therapy
post-procedure care
control examinations
symptomatic treatment

Other

cost of radiopharmaceuticals
cost of essential medicines
cost of essential materials
outpatient admission
nursing service
discharge medical records
further recommendations

Distant service

support after the therapy to evaluate the treatment results and subsequent blood tests

Extra add-ons

Local transportation

Airport transfer

Personal coordinator

HealthDocs translate

Language Assistance

AiroCare

AiroMedical support

Payment protection

Patient advocacy

Price match

Meet the provider

Univ. Prof. Dr. med. Werner Langsteger

theranostics, nuclear medicine, diagnostics, prostate and thyroid cancer

9.70

Excellent

Why to choose us?

Unique, specialized team

The Theranosticum Vienna, under the guidance of Univ.-Prof. Dr. Marcus Hacker, Univ.-Prof. Dr. Werner Langsteger, and Univ.-Prof. Mag. Markus Mitterhauser, specializes in nuclear medicine diagnostics and outpatient personalized therapies for various types of cancer. They are located at the Institute for Nuclear Medicine and Isotope Diagnostics at the Döbling Ambulatory and Vienna General Hospital for inpatient stay.

Personalized approach

The THERANOSTICS principle "we treat what we see" means that what was previously visible is treated. This principle enables a personalized therapy decision with radio ligand therapy, which is made exclusively in close coordination between the treating physician and the patient. Together, a suitable radiopharmaceutical is selected that binds selectively and with high precision to the surface of tumor cells, thus specifically destroying tumors and metastases while minimizing damage to the surrounding healthy tissue.

Life-changer for metastatic prostate cancer

The treatment can significantly increase the quality of life and extend the life span due to its good tolerability. Numerous studies have shown that it can produce good results, particularly in treating prostate cancer.

Customize this offer

If you're not seeing exactly what you need here, send your custom request. You can discuss the content, specifics, price & timeline to create a personalized plan.

Location

Heiligenstädter Str., 55-63, 1190 Vienna Austria

FAQ

What is nuclear medicine?

Nuclear medicine is a medical specialty that employs small amounts of radioactive materials, also known as radioactive isotopes or radioisotopes, to diagnose and treat various diseases. These radioactive materials are used as radiotracers for diagnostics, such as 68Gallium, and radiopharmaceuticals for treatment, such as 177Lutetium. Nuclear medicine is commonly utilized to diagnose and treat cancer. Theranostics is a specialized field of nuclear medicine.